1035230-24-0

Basic information

• Product Name: 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine
• Synonyms: 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine;2-Isopropoxy-5-Methyl-4-piperidin-4-yl-phenylaMine;5-Methyl-2-(1-Methylethoxy)-4- (4-piperidinyl)- BenzenaMine;EOS-60652
• CAS NO: 1035230-24-0
• Molecular Formula: C₁₅H₂₄N₂O
• Molecular Weight: 248.36386
• Mol File: 1035230-24-0.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 390.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.023±0.06 g/cm3(Predicted)
• PKA: 10.18±0.10(Predicted)
• CAS DataBase Reference: 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine(1035230-24-0)
• EPA Substance Registry System: 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine(1035230-24-0)

Safety Data

• Hazardous Substances Data: 1035230-24-0(Hazardous Substances Data)

Usage

General Description

2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine is a chemical compound with the molecular formula C15H23NO and a molecular weight of 233.35 g/mol. It is a white to off-white solid with a melting point of 95-96°C. 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine is widely used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceutical products. It has also been studied for its potential use in the treatment of neurological and psychiatric disorders. Additionally, 2-isopropoxy-5-Methyl-4-(piperidin-4-yl)benzenaMine has been found to exhibit certain antimicrobial and antibacterial properties, making it a versatile and valuable compound in the field of medicine and drug development.

Upstream product

• 301673-14-3 tert-butyl 4-iodopiperidine-1-carboxylate 
• 3612-20-2 1-phenylmethyl-4-piperidone 
• 41661-47-6 piperidin-4-one 
• 1692-15-5 4-pyridylboronic acid 
• 1402045-53-7 N-(2-isopropoxy-5-methylphenyl)acetamide 
• 78944-97-5 1-isopropoxy-4-methyl-2-nitrobenzene 
• 1202858-68-1 1-bromo-5-isopropoxy-2-methyl-4-nitrobenzene 
• 64695-96-1 1-bromo-5-fluoro-2-methyl-4-nitrobenzene 
• 1422-53-3 2-bromo-4-fluorotoluene 
• 119-33-5 4-methyl-2-nitrophenol 

Downstream Products

• 1032903-63-1 4-(4-amino-5-isopropoxy-2-methylphenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1380575-43-8 5-chloro-N²-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N⁴-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine hydrochloride 
• 1445894-96-1 N₂-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N₄-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine 
• 1445895-03-3 5-chloro-N₂-(2-isopropoxy-5-methyl-4-(1-ethylpiperidin-4-yl)phenyl)-N₄-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine 
• 1445895-04-4 5-chloro-N₂-(2-isopropoxy-5-methyl-4-(1-isopropylpiperidin-4-yl)phenyl)-N₄-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine 
• 1445895-08-8 5-chloro-N₂-(4-(1-(2,2-difluoroethyl)piperidin-4-yl)-2-isopropoxy-5-methylphenyl)-N₄-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine 
• 1190399-47-3 1-(4-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)-2-(dimethylamino)ethanone 
• 1445895-25-9 2-(4-(5-isopropoxy-4-((4-((2-(isopropylsulfonyl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)-2-methylphenyl)piperidin-1-yl)ethanol 
• 1445895-27-1 N₂-(2-isopropoxy-4-(1-(2-methoxyethyl)piperidin-4-yl)-5-methylphenyl)-N₄-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine 
• 1032903-64-2 4-(4-{5-chloro-4-[2-(propane-2-sulfonyl)phenylamino]pyrimidin-2-ylamino}-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylic acid tert-butyl ester 
• 1445894-97-2 5-chloro-N₄-(2-(cyclobutylsulfonyl)phenyl)-N₂-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)pyrimidine-2,4-diamine 
• 1190399-91-7 5-chloro-N²-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N⁴-[2-(isopropylsulfonyl)phenyl]pyrimidine-2,4-diamine dihydrochloride 

Relevant articles and documents

Preparation method and application of ceritinib intermediate

The invention relates to a preparation method and application of a ceritinib intermediate, in particular to a preparation process of an intermediate which is 2,5-dichloro-N-(2-(isopropylsulfonyl) phenyl)pyrimidine-4-amine, and belongs to the field of medicine synthesis. The preparation method includes the detailed following steps that a compound 1-a, a compound 1-b, palladium acetate, 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene and alkali are added into a solvent, a reaction is conducted, and then the ceritinib intermediate can be prepared. The route is simple and short, operation is easy,production costs are lowered, and the preparation method is suitable for large-scale industrialized production.

ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

An ALK kinase inhibitor compound as represented by Formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.

Ceritinib synthesis intermediate and preparation method thereof

The invention provides a synthesis intermediate 8 of an anti-tumor drug ceritinib, a preparation method thereof, and an application of the intermediate 8 in synthesizing ceritinib. The preparation method of the intermediate 8 comprises the following steps: step (1), a compound 1 and an acid HX are subjected to salt formation, such that a compound 7 is obtained; step (2), the compound 7 is reduced through sodium borohydride, such that the compound 8 is obtained. The reaction formula is as the following. With prior arts, expensive platinum oxide is needed as a hydrogenation catalyst for preparing an intermediate 2 in a next step. With the intermediate 8, the above problem is avoided. Therefore, the intermediate 8 is suitable to be used in industrialized production of ceritinib.